Treatment of pityriasis rubra pilaris with ustekinumab

British Journal of Dermatology

Volumn 163, Issue 3, 2010, Pages 655-656

  Wohlrab, J ^a   Kreft, B ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

pityriasis rubra pilaris; ustekinumab

Indexed keywords

ETRETIN; PSORALEN; USTEKINUMAB;

ADULT; CASE REPORT; CLINICAL EFFECTIVENESS; DRUG EFFICACY; ERYTHRODERMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERKERATOSIS; LETTER; MALE; MONOTHERAPY; PALMOPLANTAR KERATODERMA; PITYRIASIS RUBRA PILARIS; PRIORITY JOURNAL; PSORIASIS; PUVA; SKIN BIOPSY; TREATMENT OUTCOME; TREATMENT RESPONSE; TUBERCULOSIS; VIRUS HEPATITIS;

ADULT; ANTIBODIES, MONOCLONAL; BIOPSY; DERMATOLOGIC AGENTS; HUMANS; IMMUNOLOGIC FACTORS; MALE; PITYRIASIS RUBRA PILARIS; TREATMENT OUTCOME;

EID: 77955891631     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09855.x     Document Type: Letter

References (3)

1. Griffiths WAD. Pityriasis rubra pilaris. Clin Exp Dermatol 1980 5:105 112.
2. Müller H, Gattringer C, Zelger B et al. Infliximab monotherapy as first-line treatment for adult-onset pityriasis rubra pilaris: case report and review of the literature on biologic therapy. J Am Acad Dermatol 2008 59:S65 70.
3. Klein A, Szeimies R-M, Landthaler M, Karrer S. Exacerbation of pityriasis rubra pilaris under efalizumab therapy. Dermatology 2007 215:72 5.